Leukemia, Myelodysplasia, Transplantation
News
Interventions can ease insomnia in cancer patients
Credit: RelaxingMusic A new study suggests cancer patients struggling with insomnia can choose between 2 behavioral interventions to obtain...
News
Antipsychotic drug is active against T-ALL
Experiments in zebrafish have shown that a 50-year-old antipsychotic medication called perphenazine can actively combat T-cell acute lymphoblastic...
News
Deaths from leukemia, NHL declining in the UK
Credit: National Cancer Institute-Mathews Media Group Deaths from leukemia and non-Hodgkin lymphoma (NHL) are on the decline in the UK, but these...
News
AML scoring system could optimize treatment
Credit: NIGMS A scoring system that combines genetic and epigenetic changes could help guide therapy for acute myeloid leukemia (AML), according...
News
Leukemia is leading cause of cancer death among young Americans
receiving chemotherapy Credit: Rhoda Baer Leukemia is the leading cause of cancer death in the US for men under 40 and women aged 20 and younger...
News
Out-of-pocket costs hinder adherence to imatinib
Credit: CDC When their share of prescription costs becomes too high, many patients with chronic myeloid leukemia (CML) will skip doses of...
News
Internists may be ill-equipped to care for childhood cancer survivors
Credit: CDC A survey of general internists suggests a few obstacles may prevent these physicians from providing optimal care for childhood cancer...
News
Survey: Internists lack tools to care for survivors of childhood cancer
Major finding: Only 37%, 27%, and 25% of respondents reported being "somewhat comfortable" or "comfortable" caring for survivors of Hodgkin...
Conference Coverage
Anticoagulation reaped survival benefit in leukemia patients with DVT
Major finding: Median survival has not been reached in the anticoagulation group and was 9 months in controls (P = .02).Data source: A...
Conference Coverage
CAR-T cells drive ALL into remission
Major finding: Anti-CD19 chimeric antigen receptor T cells induced complete responses in 10 of 16 children and young adults with relapsed/...
News
Ponatinib may be returning to market with new safety measures
The US Food and Drug Administration (FDA) is requiring that a number of safety measures be adopted, including changes to ponatinib’s label to...